Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Retained Earnings (2021 - 2025)

Indivior Pharmaceuticals has reported Retained Earnings over the past 5 years, most recently at -$30.0 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$30.0 million for Q4 2025, up 16.67% from a year ago — trailing twelve months through Dec 2025 was -$30.0 million (up 16.67% YoY), and the annual figure for FY2025 was -$30.0 million, up 16.67%.
  • Retained Earnings for Q4 2025 was -$30.0 million at Indivior Pharmaceuticals, up from -$32.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for INDV hit a ceiling of -$30.0 million in Q4 2025 and a floor of -$1.3 billion in Q4 2021.
  • Median Retained Earnings over the past 5 years was -$162.0 million (2023), compared with a mean of -$426.9 million.
  • Biggest five-year swings in Retained Earnings: changed 0.0% in 2022 and later skyrocketed 87.5% in 2024.
  • Indivior Pharmaceuticals' Retained Earnings stood at -$1.3 billion in 2021, then changed by 0.0% to -$1.3 billion in 2022, then surged by 77.76% to -$288.0 million in 2023, then skyrocketed by 87.5% to -$36.0 million in 2024, then increased by 16.67% to -$30.0 million in 2025.
  • The last three reported values for Retained Earnings were -$30.0 million (Q4 2025), -$32.0 million (Q3 2025), and -$33.0 million (Q2 2025) per Business Quant data.